Validation of the Single-item Sleep Quality Scale
Cross-cultural Adaptation Into German and Italian, Validation, Reproducibility, and Responsiveness of the Single-item Sleep Quality Scale in Spine Patients
Schulthess Klinik
240 participants
Oct 1, 2024
OBSERVATIONAL
Conditions
Summary
The single-item sleep quality scale (SQS) allows patients to provide a self-assessment of sleep quality over a 7-day recall period without significant additional burden. However, the SQS has not yet been utilized or validated in patients with spine pathologies. The main purpose of this study is to cross-culturally adapt the SQS from English to German and Italian and to test its validity in patients with back disorders. The study will be conducted in two stages. The first stage will involve the translation and cross-cultural adaptation of the SQS from English to German and Italian. The second stage will involve the evaluation of the instrument's face, content, and construct validity, reproducibility, and responsiveness in patients with back disorders.
Eligibility
Inclusion Criteria5
- both male and female patients
- German-speaking or Italian-speaking
- diagnosis of spine pathology
- age ≥ 14 years
- cognitively intact (self-reported)
Exclusion Criteria5
- pregnancy (self-reported)
- medical and/or pharmacological treatment for sleep disorders
- melatonin intake
- daily use of smart-watch or applications for automatic sleep detection
- inability to give informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
For the pilot testing, each patient will complete the pre-final version of the SQS. The patients involved in the field study will have to fill in the SQS twice before treatment, one week apart, to assess reproducibility of the scale and a third time at 3 months after treatment (surgical or conservative) to assess the responsiveness of the scale.
The patients involved in the field test will have to fill in the PSQI twice before treatment, one week apart, to assess reproducibility of the scale and a third time at 3 months after treatment (surgical or conservative) to assess the responsiveness of the scale.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06612853